France Based Ennov Gets Growth Investment From Bregal Sagemount

As part of the transaction, Gene Yoon, Curt Witte, and Harrison Brunelli from Sagemount, along with Alexis Saada from Ardian, will join Ennov’s board of directors.

The company plans to use the investment to accelerate global expansion, enhance AI-driven capabilities, and strengthen its product offering and go-to-market strategy.

Read Also - Biotech-Based Efferon Raises €2.5M To Expand Blood Purification Technology

Founded and led by CEO Olivier Pâris, Ennov offers a unified software platform that helps life sciences organizations manage regulatory, quality, clinical, commercial, and pharmacovigilance data in one system.

Its integrated architecture improves compliance, adoption and operational efficiency through AI-enabled workflows.

The platform is used by more than 650 companies and 500,000 users worldwide, supporting critical processes across the global life sciences industry.

“We were looking for partners who understand the complexity of our customers’ environments and the opportunity ahead for integrated and AI-enabled software in life sciences,” said Olivier Pâris, Founder and CEO of Ennov. “Sagemount and Ardian bring that perspective, and we look forward to continuing to build innovative solutions that support our customers’ most critical processes.”

About Ennov

Founded in 1999, Ennov is a software company that helps life sciences and other regulated industries manage important information in one place. Its platform brings together quality, regulatory, clinical and safety data, making it easier for companies to stay compliant, work efficiently and collaborate globally.